INDIANAPOLIS - Elevance Health, Inc. (NYSE: ELV), previously known as Anthem (NYSE:ELV), Inc., has finalized its acquisition of Paragon Healthcare, a Texas-based provider of infusion services, the company announced today. This move is expected to enhance Elevance Health's multi-site infusion and specialty pharmacy capabilities.
Paragon Healthcare specializes in delivering infusible and injectable therapies, serving over 35,000 patients through more than 40 ambulatory infusion centers and home infusion pharmacies across eight states. The acquisition is set to deepen Elevance Health's commitment to providing access to specialty medications for individuals with chronic and complex conditions.
According to Pete Haytaian, Executive Vice President of Elevance Health and President of Carelon, the health services division which includes CarelonRx, the pharmacy services segment, the integration of Paragon Healthcare is poised to offer patients greater flexibility in how they receive their medications. Haytaian emphasized that this strategic move aims to "remove barriers to care, increase medication adherence, lower costs of care, and better support members' whole health."
Elevance Health plans to expand Paragon Healthcare's geographical reach and enhance its therapeutic offerings to ensure timely and convenient access to medications for its members. The financial terms of the acquisition were not disclosed in the statement.
Elevance Health, serving more than 115 million people, offers a broad portfolio of medical, digital, pharmacy, behavioral, clinical, and complex care solutions. The company's purpose is to improve the health of humanity by supporting consumers, families, and communities throughout their care journeys.
This acquisition is part of Elevance Health's broader strategy to provide integrated healthcare services and follows a trend of consolidation in the healthcare industry as companies seek to offer more comprehensive services.
The information for this article is based on a press release statement by Elevance Health, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.